Health
NIH provides additional support for large scale study of Alzheimer’s disease biomarkers – News-Medical.Net
To meet the pressing need to better understand the prevalence, progression, and clinical impact of Alzheimer’s disease among Mexican Americans, the National Institutes of Health has added funding for more biomarker measures, including positron emission tomogr…
Reviewed by Emily Henderson, B.Sc.Sep 14 2020
To meet the pressing need to better understand the prevalence, progression, and clinical impact of Alzheimer’s disease among Mexican Americans, the National Institutes of Health (NIH) has added funding for more biomarker measures, including positron emission tomography (PET) imaging, to the ongoing Health and Aging Brain Among Latino Elders (HABLE) Study.
NIH’s National Institute on Aging (NIA) awarded new support that is expected to total $45.5 mi…
-
Noosa News19 hours agoYoung voices shape Sunshine Coast’s future
-
Business19 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News17 hours agoAnother All-Star Cast, Another Tale of Family Chaos: The Trailer for Wes Anderson’s ‘The Phoenician Scheme’ Is Here
-
Business16 hours agoshould I buy hedged or unhedged ASX US-focused ETFs?